Korean Cohort of 2.9 Million Shows 28% Higher Childhood Hospitalization After Prenatal Opioid Exposure

Researchers analyzed linked national health insurance records, classifying exposure as two or more maternal opioid prescriptions and tracking admissions up to age 14. They applied propensity-score matching and within-family sibling contrasts to reduce confounding by indication and shared environment. Admissions increased for infections, respiratory, gastrointestinal, and genitourinary diagnoses; the association attenuated markedly after sibling adjustment, indicating both possible biological effects and residual family-level factors.

Prior U.S. and Nordic registry studies reported similar signals but were limited by shorter follow-up or lack of dose data. The Korean dataset’s near-complete prescription capture and 14-year span allowed separation of low- versus high-dose effects (aIRR 1.19 vs 1.40), an advance over earlier work. Yet electronic records cannot confirm actual consumption, and unmeasured maternal pain severity or co-medications remain possible confounders.

Guidelines already advise minimizing opioids in pregnancy; these findings support targeted postnatal surveillance for exposed infants rather than blanket avoidance. Next steps require prospective cohorts with pharmacy dispensing verification and neurodevelopmental endpoints to test whether early interventions alter trajectories.

Evidence quality note: This is a large observational cohort with sibling controls; it shows association but cannot establish causation, and replication in independent populations with granular exposure data is required.